TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.
 

Statistics about Autoimmune thyroid diseases




Prevalence and incidence statistics for Autoimmune thyroid diseases:

see also prevalence and incidence page for Autoimmune thyroid diseases

Prevalance of Autoimmune thyroid diseases: 4 out of 100 women some type of autoimmune thyroid disease

Prevalance Rate: approx 1 in 50 or 2.00% or 5.4 million people in USA [about data]

Prevalance of Autoimmune thyroid diseases: Autoimmune thyroid diseases afflict as many as 4 out of 100 women and are frequently found in families where there are other autoimmune diseases. (Source: excerpt from Understanding Autoimmune Disease: NIAID)

About statistics:

This page presents a variety of statistics about Autoimmune thyroid diseases. The term 'prevalence' of Autoimmune thyroid diseases usually refers to the estimated population of people who are managing Autoimmune thyroid diseases at any given time. The term 'incidence' of Autoimmune thyroid diseases refers to the annual diagnosis rate, or the number of new cases of Autoimmune thyroid diseases diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

Major Disease Research

Research
symptoms, treatments,
and misdiagnosis
of major diseases.

Multiple Symptom
Checker

Check one
or many
symptoms
 
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.